HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Alexander Schramm Selected Research

Neuroblastoma

10/2015Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
10/2015Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.
8/2015Mutational dynamics between primary and relapse neuroblastomas.
3/2015miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin.
11/2014Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells.
1/2014Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling.
9/2013MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A.
8/2013Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cells.
2/2013Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma.
1/2013Focal DNA copy number changes in neuroblastoma target MYCN regulated genes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Alexander Schramm Research Topics

Disease

46Neuroblastoma
10/2015 - 03/2002
34Neoplasms (Cancer)
10/2015 - 01/2005
5Neoplasm Metastasis (Metastasis)
01/2013 - 03/2007
3Medulloblastoma
11/2013 - 07/2012
2Carcinoma (Carcinomatosis)
10/2015 - 11/2011
2Retinoblastoma (Glioblastoma, Retinal)
09/2012 - 09/2005
2Osteonecrosis (Kienbock's Disease)
10/2011 - 02/2011
2Pathologic Constriction (Stenosis)
07/2009 - 05/2007
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2008 - 03/2003
1Infection
12/2015
1Necrosis
12/2015
1Breast Neoplasms (Breast Cancer)
01/2014
1Colonic Neoplasms (Colon Cancer)
09/2013
1Chromosome Aberrations (Chromosome Abnormalities)
07/2012
1Graves Disease (Basedow Disease)
05/2012
1Prostatic Neoplasms (Prostate Cancer)
11/2011
1Exophthalmos (Proptosis)
09/2010
1Ganglioneuroblastoma
05/2009
1Ganglioneuroma
05/2009
1Oropharyngeal Neoplasms
12/2008
1Genomic Instability
10/2008
1Chromosomal Instability (Chromosome Stability)
10/2008
1Inflammation
10/2006

Drug/Important Bio-Agent (IBA)

13Messenger RNA (mRNA)IBA
10/2015 - 11/2005
13MicroRNAs (MicroRNA)IBA
05/2015 - 02/2008
6DNA (Deoxyribonucleic Acid)IBA
10/2015 - 09/2005
4Small Interfering RNA (siRNA)IBA
03/2015 - 11/2008
3Complementary DNA (cDNA)IBA
03/2015 - 03/2005
3Lysine (L-Lysine)FDA Link
09/2013 - 03/2009
3Histones (Histone)IBA
09/2013 - 03/2009
3Phosphotransferases (Kinase)IBA
07/2012 - 03/2002
3anaplastic lymphoma kinaseIBA
07/2012 - 09/2010
2DNA VaccinesIBA
10/2015 - 08/2009
2trkA ReceptorIBA
11/2014 - 08/2013
2Conditioned Culture MediaIBA
11/2014 - 08/2013
2Carbon MonoxideIBA
08/2013 - 09/2012
2RNA (Ribonucleic Acid)IBA
02/2013 - 09/2005
2Transcription Factors (Transcription Factor)IBA
11/2011 - 11/2008
2Interleukin-2 (IL2)IBA
02/2010 - 03/2007
2First StepIBA
06/2009 - 01/2008
2Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
05/2009 - 01/2005
2trkB ReceptorIBA
10/2008 - 10/2005
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2008 - 01/2005
2betaIG-H3 protein (keratoepithelin)IBA
01/2008 - 05/2006
2activin AIBA
05/2006 - 01/2005
1Telomerase (Telomerase Reverse Transcriptase)IBA
10/2015
1PeptidesIBA
10/2015
1AntigensIBA
10/2015
1Genetic Markers (Genetic Marker)IBA
10/2015
1Cyclin-Dependent Kinases (cdk Proteins)IBA
06/2015
1Differentiation AntigensIBA
11/2014
1Adenocarcinoma of lungIBA
01/2014
1Proteins (Proteins, Gene)IBA
02/2013
1GTP-Binding Proteins (G-Protein)IBA
01/2013
13- (2- carboxypiperazin- 4- yl)propyl- 1- phosphonic acid (CPP)IBA
01/2013
1EnzymesIBA
01/2013
1cetuximab (Erbitux)FDA Link
01/2013
1Immunoglobulin G (IgG)IBA
01/2013
1Retinaldehyde (Retinal)IBA
09/2012
1Oncogene Proteins (Oncogene Protein)IBA
07/2012
1nutlin 3IBA
07/2012
1LBW242IBA
05/2012
1X-Linked Inhibitor of Apoptosis ProteinIBA
05/2012
1Tretinoin (Retinoic Acid)FDA LinkGeneric
02/2012
1Alprostadil (Muse)FDA LinkGeneric
01/2012
1tyrosine receptor (receptor, tyrosine)IBA
08/2011
1BI 2536IBA
02/2011
1polo-like kinase 1IBA
02/2011
1DiphosphonatesIBA
02/2011
1Biological Markers (Surrogate Marker)IBA
11/2010
1Lymphotoxin-alpha (Lymphotoxin)IBA
02/2010
1Interferon-gamma (Interferon, gamma)IBA
02/2010
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
08/2009
1Interleukin-12 (IL 12)IBA
08/2009
1Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
05/2009
1Histone DemethylasesIBA
03/2009
1Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA
03/2009
1ChromatinIBA
03/2009
1NeurotensinIBA
11/2008
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
10/2008
1Protein Isoforms (Isoforms)IBA
02/2008
1tissue-factor-pathway inhibitor 2 (PP5)IBA
01/2008
1decitabine (5-aza-2'-deoxycytidine)FDA Link
01/2008
1CytokinesIBA
03/2007
1Chemokine CX3CL1IBA
03/2007
1GD2 gangliosideIBA
03/2007
1HydrogelIBA
10/2006
1Extracellular Matrix ProteinsIBA
05/2006

Therapy/Procedure

6Heterologous Transplantation (Xenotransplantation)
03/2015 - 03/2009
2Decompression
05/2012 - 09/2010
2Computer-Assisted Surgery (Image Guided Surgery)
05/2012 - 01/2012
2Carotid Endarterectomy
07/2009 - 05/2007
1Transplants (Transplant)
12/2015
1Combined Modality Therapy
10/2015
1Drug Therapy (Chemotherapy)
05/2012
1Osteotomy
05/2012
1Bone Transplantation (Bone Grafting)
10/2011
1Stem Cell Transplantation
02/2010
1Radiotherapy
12/2008
1Aftercare (After-Treatment)
12/2008